Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Exxon Mobil’s shares fell after the company warned its fourth-quarter earnings will take a hit from lower crude prices and narrowing refining margins during the final three months of 2024.

Retail traders who had developed a taste for gambling on speculative stocks were facing a day of reckoning on Wednesday as many of their favorite trades suffered a startling meltdown.

Mizuho has unveiled its January US Top Picks, spotlighting Chewy, GE Vernova, Enliven Therapeutics, Quest Diagnostics, DuPont ...

KUWAIT CITY - Kuwait Finance House (KFH) announced the successful issuance of a 5-year Senior Unsecured Sukuk of US$1 bn. The Sukuk will be listed on the London Stock Exchange. This is the second ...

HSBC lowered its rating on Advanced Micro Devices stock amid several concerns including the chipmaker's ability to compete ...

Exxon Mobil (NYSE:XOM) -1.4% in Wednesday's trading after saying its Q4 earnings were hurt by lower crude prices and narrower ...

Exxon Mobil profits will likely miss fourth-quarter-earnings estimates by close to 20%, one analyst argued as he trimmed his ...

Mizuho upgraded Twilio (TWLO) to Outperform from Neutral with a price target of $140, up from $85, ahead of the company’s January 23 investor ...

The firm said that the unsecured $1.5 billion revolving credit facility through 2030 replaces another $1.5 billion credit facility through 2026.

The latest Job Openings and Labor Turnover Survey (JOLTS) data paints a mixed picture of the labor market, with more job ...

In a report released today, Vijay Rakesh from Mizuho Securities maintained a Hold rating on Qorvo (QRVO – Research Report), with a price target ...